Riboflavin 5-phosphate Ophthalmic Solution
Brand names: Photrexa Cross-Linking Kit
Category: Ophthalmology
FDA status: To Be Discontinued · Last FDA update: Jan 20, 2026 · First posted: Jan 20, 2026 · 1 manufacturers, 1 listed presentations
As of Jan 20, 2026, the FDA lists Riboflavin 5-phosphate Ophthalmic Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03) NDC 25357-025-03 |
Glaukos Corporation | Not specified | Discontinuing manufacture of the product as of July 2026. |
Related medications in shortage
Other Ophthalmology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Riboflavin 5-phosphate Ophthalmic Solution (FDA data as of Jan 20, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Riboflavin 5-phosphate Ophthalmic Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/riboflavin-5-phosphate-ophthalmic-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).